The Ceftriaxone Sodium, cataloged under National Stock Number 6505-01-229-3149, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Sandoz Inc.. Government technical data includes 7 specifications, cited from the U.S. Government catalog. The record lists 3 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-229-3149 |
| Primary Part Number | NDC00781-3209-95 |
| Item Name | Ceftriaxone Sodium |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Sandoz Inc. |
| Status | ACTIVE |
| Administration | INTRAMUSCULAR OR INTRAVENOUS |
| Primary Container Content Quantity | 2.000 GRAMS OF ACTIVE INGREDIENT G |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | VIAL |
| Physical Form | POWDER |
| Active Medicament Medicinal Strength | 2.000 GRAMS CEFTRIAXONE EQUIVALENT G |
| Total Primary Container Quantity | 10 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC00781-3209-95 PRIMARY | Sandoz Inc. (USA) |
| NDC63323-0347-20 PRIMARY | Fresenius Kabi, Llc (USA) |
| 304720 PRIMARY | Fresenius Kabi, Llc (USA) |
| Reference | Meaning |
|---|---|
| NDC00409-7335-03 | 5/2 Secondary reference U.S. Government activity |
NSN 6505-01-229-3149 is a Ceftriaxone Sodium, manufactured by Sandoz Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-229-3149 has 3 manufacturer part numbers on file: NDC00781-3209-95 (Sandoz Inc.), NDC63323-0347-20 (Fresenius Kabi, Llc), 304720 (Fresenius Kabi, Llc).
Key specifications for NDC00781-3209-95: Administration: INTRAMUSCULAR OR INTRAVENOUS; Primary Container Content Quantity: 2.000 GRAMS OF ACTIVE INGREDIENT G; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: VIAL. 7 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.